相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Resveratrol induces apoptosis MH7A human rheumatoid arthritis synovial cells in a sirtuin 1-dependent manner
Hiroshi Nakayama et al.
RHEUMATOLOGY INTERNATIONAL (2012)
Resveratrol reverses monocrotaline-induced pulmonary vascular and cardiac dysfunction: A potential role for atrogin-1 in smooth muscle
Michael L. Paffett et al.
VASCULAR PHARMACOLOGY (2012)
SIRT1 overexpression in the rheumatoid arthritis synovium contributes to proinflammatory cytokine production and apoptosis resistance
Fabienne Niederer et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
SIRT1 Acts as a Modulator of Neointima Formation Following Vascular Injury in Mice
Li Li et al.
CIRCULATION RESEARCH (2011)
Repression of P66Shc Expression by SIRT1 Contributes to the Prevention of Hyperglycemia-Induced Endothelial Dysfunction
Shuang Zhou et al.
CIRCULATION RESEARCH (2011)
Resveratrol with antioxidant activity inhibits matrix metalloproteinase via modulation of SIRT1 in human fibrosarcoma cells
Soo-Jin Lee et al.
LIFE SCIENCES (2011)
Activation of Sirt1 by Resveratrol Inhibits TNF-α Induced Inflammation in Fibroblasts
Xiaoxia Zhu et al.
PLOS ONE (2011)
SIRT1 decreases Lox-1-mediated foam cell formation in atherogenesis
Sokrates Stein et al.
EUROPEAN HEART JOURNAL (2010)
Heme oxygenase-1/p21WAF1 mediates peroxisome proliferator-activated receptor-γ signaling inhibition of proliferation of rat pulmonary artery smooth muscle cells
Manxiang Li et al.
FEBS JOURNAL (2010)
SIRT1 Suppresses Activator Protein-1 Transcriptional Activity and Cyclooxygenase-2 Expression in Macrophages
Ran Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Resveratrol Prevents Monocrotaline-Induced Pulmonary Hypertension in Rats
Anna Csiszar et al.
HYPERTENSION (2009)
Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents
Mohamed Izikki et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Protective mechanisms of resveratrol against ischemia-reperfusion-induced damage in hearts obtained from Zucker obese rats: the role of GLUT-4 and endothelin
Istvan Lekli et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Endothelium-specific overexpression of class III deacetylase SIRT1 decreases atherosclerosis in apolipoprotein E-deficient mice
Qing-jun Zhang et al.
CARDIOVASCULAR RESEARCH (2008)
Emerging roles of SIRT1 in vascular endothelial homeostasis
Michael Potente et al.
CELL CYCLE (2008)
Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span
Kevin J. Pearson et al.
CELL METABOLISM (2008)
Transcriptional targets of sirtuins in the coordination of mammalian physiology
Jerome N. Feige et al.
CURRENT OPINION IN CELL BIOLOGY (2008)
Strategic targets to induce neovascularization by resveratrol in hypercholesterolemic rat myocardium: Role of caveolin-1, endothelial nitric oxide synthase, hemeoxygenase-1, and vascular endothelial growth factor
Suresh Varma Penumathsa et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Pulmonary arterial hypertension: current therapeutic strategies
Aniket Puri et al.
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE (2007)
Resveratrol increases vascular oxidative stress resistance
Zoltan Ungvari et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
GCIP/CCNDBP1, a helix-loop-helix protein, suppresses tumorigenesis
Wenbin Ma et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase
Mahesh Thirunavukkarasu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Pulmonary arterial hypertension and rheumatic diseases-from diagnosis to treatment
O. Distler et al.
RHEUMATOLOGY (2006)
Resveratrol attenuates TNF-α-induced activation of coronary arterial endothelial cells:: role of NF-kB inhibition
Anna Csiszar et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Activation of soluble guanylate cyclase reverses experimental pulmonary hypertension and vascular remodeling
R Dumitrascu et al.
CIRCULATION (2006)
Vascular dysfunction in aging: Potential effects of resveratrol, an anti-inflammatory phytoestrogen
N Labinskyy et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Therapeutic potential of resveratrol: the in vivo evidence
Joseph A. Baur et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Sildenafil citrate therapy for pulmonary arterial hypertension
N Galiè et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Reversal of experimental pulmonary hypertension by PDGF inhibition
RT Schermuly et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study)
FM Wigley et al.
ARTHRITIS AND RHEUMATISM (2005)
Serotonin transporter inhibition prevents and reverses monocrotaline-induced pulmonary hypertension in rats
C Guignabert et al.
CIRCULATION (2005)
Clinical efficacy of sildenafil in primary pulmonary hypertension - A randomized, placebo-controlled, double-blind, crossover study
BKS Sastry et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
R-cadherin:: β-catenin complex and its association with vascular smooth muscle cell proliferation
SC Slater et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Long-term treatment with oral sildenafil is safe and improves functional capacity and hemodynamics in patients with pulmonary arterial hypertension
ED Michelakis et al.
CIRCULATION (2003)
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
KT Howitz et al.
NATURE (2003)
Beraprost therapy for pulmonary arterial hypertension
RJ Barst et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and Doppler measures in patients with pulmonary arterial hypertension
N Galiè et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Cyclin D1 serves as a cell cycle regulatory switch in actively proliferating cells
DW Stacey
CURRENT OPINION IN CELL BIOLOGY (2003)
Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension:: With pulmonary arterial hypertension:: A randomized, double-blind, placebo-controlled trial
N Galiè et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Bosentan therapy for pulmonary arterial hypertension
LJ Rubin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Angiotensin-converting enzyme inhibitor preserves p21 and endothelial nitric oxide synthase expression in monocrotaline-induced pulmonary arterial hypertension in rats
S Kanno et al.
CIRCULATION (2001)
Sildenafil in primary pulmonary hypertension.
S Prasad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue.
MM Hoeper et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
